Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6847
Rank
โ‚ฌ0.51 B
Marketcap
25,91ย โ‚ฌ
Share price
-0.78%
Change (1 day)
-13.97%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : โ‚ฌ44.17 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are โ‚ฌ44.17 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31โ‚ฌ40.61 M14.91%
2023-12-31โ‚ฌ35.34 M